BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21414892)

  • 1. [General overview on DNA repair].
    Pourquier P; Robert J
    Bull Cancer; 2011 Mar; 98(3):229-37. PubMed ID: 21414892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
    Sukhanova MV; Lavrik OI; Khodyreva SN
    Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PARP inhibitors: significant progress in cancer therapy].
    Dantzer F; Noel G; Schreiber V
    Bull Cancer; 2011 Mar; 98(3):277-90. PubMed ID: 21459712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy.
    Plummer ER; Calvert H
    Clin Cancer Res; 2007 Nov; 13(21):6252-6. PubMed ID: 17975135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
    Yap TA; Sandhu SK; Carden CP; de Bono JS
    CA Cancer J Clin; 2011; 61(1):31-49. PubMed ID: 21205831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose)polymerase (PARP) inhibitors: from bench to bedside.
    Plummer R
    Clin Oncol (R Coll Radiol); 2014 May; 26(5):250-6. PubMed ID: 24602564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
    Boulikas T
    Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of DNA double-strand breaks in toxicity and carcinogenesis.
    Vamvakas S; Vock EH; Lutz WK
    Crit Rev Toxicol; 1997 Mar; 27(2):155-74. PubMed ID: 9099517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair pathways and their implication in cancer treatment.
    Pallis AG; Karamouzis MV
    Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy.
    Berger NA; Berger SJ; Gerson SL
    Anticancer Drug Des; 1987 Oct; 2(2):203-9. PubMed ID: 3329525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes acting at strand interruptions in DNA.
    Lindahl T; Satoh MS; Dianov G
    Philos Trans R Soc Lond B Biol Sci; 1995 Jan; 347(1319):57-62. PubMed ID: 7746855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Touching base with PARPs: moonlighting in the repair of UV lesions and double-strand breaks.
    Pines A; Mullenders LH; van Attikum H; Luijsterburg MS
    Trends Biochem Sci; 2013 Jun; 38(6):321-30. PubMed ID: 23562323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A concise review of DNA damage checkpoints and repair in mammalian cells.
    Houtgraaf JH; Versmissen J; van der Giessen WJ
    Cardiovasc Revasc Med; 2006; 7(3):165-72. PubMed ID: 16945824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks.
    Yang YG; Cortes U; Patnaik S; Jasin M; Wang ZQ
    Oncogene; 2004 May; 23(21):3872-82. PubMed ID: 15021907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics.
    Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T
    Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA repair pathways and their involvement in human diseases].
    Sandovici I; Buhuşi MC; Stoica O; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):247-57. PubMed ID: 12638268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inhibitors of poly(ADP-ribose) polymerase on DNA repair, chromosomal alterations, and mutations.
    Natarajan AT; van Zeeland AA; Zwanenburg TS
    Princess Takamatsu Symp; 1983; 13():227-42. PubMed ID: 6317638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors.
    Gaymes TJ; Shall S; Farzaneh F; Mufti GJ
    Haematologica; 2008 Dec; 93(12):1886-9. PubMed ID: 18838476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of human DNA repair: an update.
    Christmann M; Tomicic MT; Roos WP; Kaina B
    Toxicology; 2003 Nov; 193(1-2):3-34. PubMed ID: 14599765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.